As R&D productivity declines and the age of blockbuster medicines reaches an end, the pharmaceutical industry is looking at ways to extend the profitable life of its products up to and beyond patent expiry.
19-Oct-2009 - Critical Pharmaceuticals has received a £1.5m ($2.4m) award to develop its hGH nasal spray, the market for which could be sizeable as company’s attempt to differentiate in response to generic...
15-Oct-2009 - ACRO says while a 12-year exclusivity period for innovative drugs is important for R&D, US legislation should include rules on trials for biosimilars
15-Oct-2009 - Packaging group Stralfors says its recent collaboration with Novo Nordisk proves that its service plan is ideal for projects with strict time-to-market requirements.
08-Oct-2009 - We look ahead to CPhI 2009 which takes place in Madrid, Spain next week and will showcase the world’s leading ingredients, contract services, machinery and biotech companies.
08-Oct-2009 - Canadian drugmaker Labopharm says its Italian API maker Gruppo Angelini has resolved all the US FDA concerns about processes used to make a once-a day version of the depression drug...
07-Oct-2009 - Its new microparticle technology licensing deal with Genentech could be worth as much as $200m (€136m) says US delivery specialist SurModics.
07-Oct-2009 - French drug major Sanofi Aventis, Israel's Teva Pharmaceutical Industries and Germany’s Ratiopharm were raided by European Commission (EC) competition officials yesterday as part of an ongoing investigation.
06-Oct-2009 - Despite the government’s “aggressive” promotion of generic drugs, pharmaceutical spending in France will continue to grow, according to new analysis by Business Monitor International (BMI).
06-Oct-2009 - Hospira has acquired the worldwide rights to filgrastim and a Croatian biologics plant from Pliva, increasing its presence in the biogenerics field, and told in-PharmaTechnologist that further expansions are possible.
29-Sep-2009 - The FDA is to establish current good manufacturing practice (cGMP) requirements for combination products to eliminate inconsistencies that could affect product safety and public health.
03-Sep-2009 - Wyeth’s battles to protect the controlled-release (CR) version of its anti-depressant Effexor are a sign of things to come according to a new Espicom report identifying 30 CR drugs likely...
03-Sep-2009 - The biosimilars sector is predicted to be worth $19.4bn (€13.6bn) by 2014, by which time the US will have overtaken Asia as the dominant market, according to a report.
26-Aug-2009 - Pfizer’s new $214.8 million (€150m) biotechnology facility in Strangnas, Sweden was inaugurated yesterday, securing the country’s future in the company’s manufacturing network according to global manufacturing president Natale Ricciardi....
24-Aug-2009 - Researchers have presented new microneedle drug delivery patches, which, using technology developed in the electronics sector, could improve compliance and treat ocular diseases.
19-Aug-2009 - Eastern Europe’s pharmaceutical market is growing at an impressive rate, but the complex regulatory rules being introduced may make it a less attractive proposition that it first appears, according to...
05-Aug-2009 - West Pharmaceutical Services’ operating income fell by 33 per cent in Q2 but the company reported that demand for some of its drug delivery technology is strong.
04-Aug-2009 - Shin Nippon Biomedical Laboratories (SNBL) has posted a positive first report on the Phase II trial of its intranasal antiemetic, which it claims is a more convenient treatment for cancer...
03-Aug-2009 - New US patents for the PKU drug Kuvan will “significantly strengthen” BioMarin’s position according to CEO Jean-Jacques Bienaime.
30-Jul-2009 - Medingo’s insulin dispensing patch has been approved by the US Food and Drug Administration (FDA), sending shares in its parent company soaring to a 12 month high.
21-Jul-2009 - Wyeth’s shareholders gave Pfizer’s $68bn (€48bn) takeover a ringing endorsement late yesterday, with 98 per cent voting in favour of the deal.
20-Jul-2009 - Rumours suggest that US drug giant Pfizer is considering a bid for Turkish generics group Abdi Ibrahim as part of its strategy of expanding in emerging markets.
07-Jul-2009 - Pfizer will invest €11m ($15.3m) in a new kilo technology R&D laboratory at its API manufacturing facility in Ringaskiddy, Ireland.
06-Jul-2009 - UK drug major GSK has paid Bristol-Myers Squibb’s (BSM) $23.2m (€16.6m) for 13 generic products that it sells in North Africa and the Middle East.
30-Jun-2009 - Mylan has followed Teva’s lead by partnering to develop follow-on biologics (FOB), with the Indian generic maker regarding Biocon as the “ideal partner” to help it enter the market. ...
18-Jun-2009 - Seven of the top ten drugs will be biopharmaceuticals by 2014 according to sector analysts Evaluate Pharma.